Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma

Clinical trial NCT00177554 · COMPLETED

Trial details

NCT number: NCT00177554
Sponsor: University of Pittsburgh
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma

Start date: 2003-11-01
Primary completion: 2007-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.